申请人:Hoechst-Roussel Pharmaceuticals Incorporated
公开号:US05234931A1
公开(公告)日:1993-08-10
This invention relates to compounds of the formula ##STR1## where X is --O--, --S-- or --NH--; Y is hydrogen, halogen and loweralkoxy; p is 1 or 2; n is 2, 3 or 4; R is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, amino, loweralkylamino, nitro, loweralkylthio, trifluoromethoxy, cyano, trifluoromethyl, ##STR2## R.sub.1 is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, carboxyl, loweralkylamino, nitro, loweralkylthio, cyano, and trifluoromethyl; m is 1 or 2; a pharmaceutically acceptable acid addition salt thereof and, where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds and compositions of this invention are useful as antipsychotic agents, as 5-HT.sub.3 receptor antagonists and as inhibitors of the reuptake of serotonin.
本发明涉及式子##STR1##的化合物,其中X是--O--,--S--或--NH--;Y是氢,卤素和低烷氧基;p为1或2;n为2、3或4;R为氢,低烷基,低烷氧基,羟基,卤素,
氨基,低烷基
氨基,硝基,低烷基
硫基,三
氟甲氧基,
氰基,三
氟甲基,##STR2## R.sub.1为氢,低烷基,低烷氧基,卤素,羟基,羧基,低烷基
氨基,硝基,低烷基
硫基,
氰基和三
氟甲基;m为1或2;其药学上可接受的酸盐和,如适用,其几何和光学异构体和外消旋混合物。本发明的化合物和组合物可用作
抗精神病药物,作为5-HT3受体拮抗剂和抑制
血清素再摄取的药物。